Aberrant food choices after satiation in human orexin-deficient narcolepsy type 1

Sleep

Volumn 39, Issue 11, 2016, Pages 1951-1959

  Van Holst, Ruth Janke ^a,b,c   Van Der Cruijsen, Lisa ^b   Van Mierlo, Petra ^d   Jan Lammers, Gert ^e,f   Cools, Roshan ^a,b   Overeem, Sebastiaan ^a,d,g   Aarts, Esther ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^e STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Habits; Narcolepsy; Obesity; Orexin; Over eating; Satiation

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; OREXIN; OXYBATE SODIUM; BIOLOGICAL MARKER;

ADULT; ARTICLE; BARRATT IMPULSIVENESS SCALE; BODY MASS; CALORIC INTAKE; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EATING HABIT; EPWORTH SLEEPINESS SCALE; FAST FOOD; FEEDING BEHAVIOR; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FOOD PREFERENCE; HUMAN; HUNGER; HYPERSOMNIA; IDIOPATHIC DISEASE; MALE; NARCOLEPSY; OBESITY; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; SATIETY; SOMNOLENCE; VOCATIONAL EDUCATION; ADOLESCENT; APPETITE; CASE CONTROL STUDY; COMPLICATION; DEFICIENCY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; APPETITE; BIOMARKERS; CASE-CONTROL STUDIES; FEEDING BEHAVIOR; FEMALE; FOOD PREFERENCES; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; OBESITY; OREXINS; SATIATION; SNACKS; YOUNG ADULT;

EID: 84995632251     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.6222     Document Type: Article

References (39)

1. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
2. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
3. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511.
4. Kok SW, Overeem S, Visscher TL, et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res 2003;11:1147-54.
5. Schuld A, Hebebrand J, Geller F, Pollmicher T. Increased body-mass index in patients with narcolepsy. Lancet 2000;355:1274-5.
6. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73.
7. Fortuyn HAD, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep 2008;31:335-41.
8. Harris GC, Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006;29:571-7.
9. Aston-Jones G, Smith RJ, Moorman DE, Richardson KA. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009;56 Suppl 1:112-21.
10. Mahler S V, Moorman DE, Smith RJ, James MH, Aston-Jones G. Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci 2014;17:1298-303.
11. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 2008;105:19480-5.
12. Sakurai T. The role of orexin in motivated behaviours. Nat Rev Neurosci 2014;15:719-31.
13. Cone JJ, McCutcheon JE, Roitman MF. Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci 2014;34:4905-13.
14. Donjacour CEHM, Pardi D, Aziz NA, et al. Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate. J Clin Sleep Med 2013;9:797-803.
15. Poli F, Plazzi G, Di Dalmazi G, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;32:1491-7.
16. Kok SW, Meinders AE, Overeem S, et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab 2002;87:805-9.
17. Dahmen N, Engel A, Helfrich J, et al. Peripheral leptin levels in narcoleptic patients. Diabetes Technol Ther 2007;9:348-53.
18. Arnulf I, Lin L, Zhang J, et al. CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency? Sleep 2006;29:1017-24.
19. Rolls BJ, Rolls ET, Rowe EA, Sweeney K. Sensory specific satiety in man. Physiol Behav 1981;27:137-42.
20. Balleine BW, O'Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010;35:48-69.
21. Tricomi E, Balleine BW, O'Doherty JP. A specific role for posterior dorsolateral striatum in human habit learning. Eur J Neurosci 2009;29:2225-32.
22. Valentin V V, Dickinson A, O'Doherty JP. Determining the neural substrates of goal-directed learning in the human brain. J Neurosci 2007;27:4019-26.
23. Hogarth L, Chase HW, Baess K. Impaired goal-directed behavioural control in human impulsivity. Q J Exp Psychol 2012;65:305-16.
24. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
25. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993;103:30-6.
26. Kaufman AS, Kaufman NL. Specific learning disabilities and difficulties in children and adolescents: psychological assessment and evaluation. Cambridge University Press, 2001.
27. van Lee L, Geelen A, van Huysduynen E, de Vries JHM, van't Veer P, Feskens EJM. The Dutch Healthy Diet index (DHD-index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J 2012;11:49.
28. Barnett V, Lewis T. Outliers in statistical data. J Wiley & Sons, 1994.
29. Sheng Z, Santiago AM, Thomas MP, Routh VH. Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry. Mol Cell Neurosci 2014;62:30-41.
30. Schuld A, Blum WF, Pollmicher T. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2002;51:660; author reply 660-1.
31. Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med 2011;7:653-8.
32. de Wit S, Watson P, Harsay H a, Cohen MX, van de Vijver I, Ridderinkhof KR. Corticostriatal connectivity underlies individual differences in the balance between habitual and goal-directed action control. J Neurosci 2012;32:12066-75.
33. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003;23:7-11.
34. España RA, Melchior JR, Roberts DCS, Jones SR. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 2011;214:415-26.
35. Lammers GJ, Pijl H, Iestra J, Langius JA, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep 1996;19:75-6.
36. Subar AF. Using Intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003;158:1-13.
37. Nedeltcheva A V, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 2009;89:126-33.
38. Hanlon EC, Benca RM, Baldo BA, Kelley AE. REM sleep deprivation produces a motivational deficit for food reward that is reversed by intra-accumbens amphetamine in rats. Brain Res Bull 2010;83:245-54.
39. Baldo BA, Hanlon EC, Obermeyer W, Bremer Q, Paletz E, Benca RM. Upregulation of gene expression in reward-modulatory striatal opioid systems by sleep loss. Neuropsychopharmacology 2013;38:2578-87.